This startup provides an AI-powered digital pathology platform for cervical cancer screening. It analyzes cervical smear images to detect abnormalities, offering fast and accurate screening in resource-limited areas.
Funding
Funding not disclosed
Founders
Product
Problem
Cervical cancer screening in resource-limited settings often faces challenges related to infrastructure, trained personnel, and efficient processing of samples, leading to delays and potential inaccuracies in diagnosis. Traditional methods can be labor-intensive and may not scale effectively to meet the needs of large populations.
Solution
Vyuhaa Med Data offers CerviAI, an AI-powered platform designed to automate and enhance cervical cytology screening. CerviAI utilizes deep learning models trained on a large dataset of cervical smear images to identify potential abnormalities with high precision. The platform can be deployed on-site via an EDGE device with cloud synchronization capabilities, making it suitable for low-resource environments. By automating slide processing, analysis, and reporting, CerviAI aims to reduce pathologist workload, accelerate turnaround times, and improve the overall accuracy of cervical cancer screening programs. The platform also supports integrated HPV DNA testing workflows for improved risk stratification.
Target Audience
The primary target audience includes OB-GYNs, hospitals, pathology labs, and screening programs seeking to improve the efficiency and accuracy of cervical cancer screening, particularly in resource-constrained environments.
Features
- AI-based triage and anomaly detection for cervical cytology
- Trained on over 2,800 cases in NABL-accredited labs
- EDGE device with cloud sync for deployment in low-resource settings
- Compatible with Hamamatsu, Grundium, and KFBio slide scanners
- Supports Liquid Based Cytology (LBC) and HPV DNA co-testing
- Digital Cytology Scanner: High-throughput whole slide imaging system optimized for cytology specimens
- Offers LBC collection kits for optimal sample preservation
- Provides access to rapid expert review for cancer, tumor, and biopsy cases via a digital platform